Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Khan, , Russell,
DOB: 29-AUG-1980 (Age: 45)
Gender: male
Address:
1 Holly well
B9 Allantown (United Kingdom)
ID: 7982-255119-2 (ECI)
Report
Date: 19-JAN-2025
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Birmingham Children's Hospital
B4 6 Birmingham (United Kingdom)
Specimen
Collected: 19-JAN-2025

Chemistry

Test 19-JAN-2025 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 255.1 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 110.8 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 181.2 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 51.8 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated total cholesterol and LDL cholesterol, while triglycerides and HDL cholesterol are within normal limits. These findings indicate increased cardiovascular risk, primarily due to high LDL. Clinical correlation and consideration of lifestyle modification or lipid-lowering therapy are recommended.